These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 7160537

  • 1. Selective effects of myo-inositol administration on sciatic and tibial motor nerve conduction parameters in the streptozocin-diabetic rat.
    Greene DA, Lewis RA, Lattimer SA, Brown MJ.
    Diabetes; 1982 Jul; 31(7):573-8. PubMed ID: 7160537
    [Abstract] [Full Text] [Related]

  • 2. Reversal of deficits in axonal transport and nerve conduction velocity by treatment of streptozotocin-diabetic rats with myo-inositol.
    Tomlinson DR, Mayer JH.
    Exp Neurol; 1985 Aug; 89(2):420-7. PubMed ID: 2410289
    [Abstract] [Full Text] [Related]

  • 3. Reduced motor nerve conduction velocity and Na(+)-K(+)-ATPase activity in rats maintained on L-fucose diet. Reversal by myo-inositol supplementation.
    Yorek MA, Wiese TJ, Davidson EP, Dunlap JA, Stefani MR, Conner CE, Lattimer SA, Kamijo M, Greene DA, Sima AA.
    Diabetes; 1993 Oct; 42(10):1401-6. PubMed ID: 8397126
    [Abstract] [Full Text] [Related]

  • 4. Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Yorek MA.
    Int J Exp Diabetes Res; 2002 Oct; 3(1):21-36. PubMed ID: 11900277
    [Abstract] [Full Text] [Related]

  • 5. A combination of the aldose reductase inhibitor, statil, and the prostaglandin E1 analogue, OP1206.alpha CD, completely improves sciatic motor nerve conduction velocity in streptozocin-induced chronically diabetic rats.
    Yasuda H, Sonobe M, Hisanaga T, Kawabata T, Maeda K, Kikkawa R, Shigeta Y.
    Metabolism; 1992 Jul; 41(7):778-82. PubMed ID: 1320179
    [Abstract] [Full Text] [Related]

  • 6. Amelioration of nerve Na(+)-K(+)-ATPase activity independently of myo-inositol level by PGE1 analogue OP-1206.alpha-CD in streptozocin-induced diabetic rats.
    Sonobe M, Yasuda H, Hisanaga T, Maeda K, Yamashita M, Kawabata T, Kikkawa R, Taniguchi Y, Shigeta Y.
    Diabetes; 1991 Jun; 40(6):726-30. PubMed ID: 1645681
    [Abstract] [Full Text] [Related]

  • 7. Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation.
    Greene DA, Lattimer SA.
    J Clin Invest; 1983 Sep; 72(3):1058-63. PubMed ID: 6309904
    [Abstract] [Full Text] [Related]

  • 8. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats.
    Cameron NE, Cotter MA, Robertson S.
    Q J Exp Physiol; 1989 Nov; 74(6):917-26. PubMed ID: 2512591
    [Abstract] [Full Text] [Related]

  • 9. Methylcobalamin improves nerve conduction in streptozotocin-diabetic rats without affecting sorbitol and myo-inositol contents of sciatic nerve.
    Sonobe M, Yasuda H, Hatanaka I, Terada M, Yamashita M, Kikkawa R, Shigeta Y.
    Horm Metab Res; 1988 Nov; 20(11):717-8. PubMed ID: 3215630
    [No Abstract] [Full Text] [Related]

  • 10. Effect of niceritrol on streptozocin-induced diabetic neuropathy in rats.
    Hotta N, Kakuta H, Fukasawa H, Koh N, Sakakibara F, Komori H, Sakamoto N.
    Diabetes; 1992 May; 41(5):587-91. PubMed ID: 1533192
    [Abstract] [Full Text] [Related]

  • 11. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.
    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, Yorek MA.
    Diabetes; 2001 Aug; 50(8):1927-37. PubMed ID: 11473057
    [Abstract] [Full Text] [Related]

  • 12. Motor nerve conduction velocity and nerve polyols in mice with short-term genetic or streptozotocin-induced diabetes.
    Whiteley SJ, Tomlinson DR.
    Exp Neurol; 1985 Aug; 89(2):314-21. PubMed ID: 3160601
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Normalization of Na(+)-K(+)-ATPase activity in isolated membrane fraction from sciatic nerves of streptozocin-induced diabetic rats by dietary myo-inositol supplementation in vivo or protein kinase C agonists in vitro.
    Kim J, Kyriazi H, Greene DA.
    Diabetes; 1991 May; 40(5):558-67. PubMed ID: 1850704
    [Abstract] [Full Text] [Related]

  • 19. Diminished specific activity of cytosolic protein kinase C in sciatic nerve of streptozocin-induced diabetic rats and its correction by dietary myo-inositol.
    Kim J, Rushovich EH, Thomas TP, Ueda T, Agranoff BW, Greene DA.
    Diabetes; 1991 Nov; 40(11):1545-54. PubMed ID: 1657670
    [Abstract] [Full Text] [Related]

  • 20. A new prostaglandin E1 analogue (TFC-612) prevents a decrease in motor nerve conduction velocity in streptozocin-diabetic rats.
    Yasuda H, Sonobe M, Hatanaka I, Yamashita M, Miyamoto Y, Terada M, Amenomori M, Kikkawa R, Shigeta Y, Motoyama Y.
    Biochem Biophys Res Commun; 1988 Jan 15; 150(1):225-30. PubMed ID: 3276309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.